Japan created universal artificial blood, new revolution in medicine.

Anemia is a big problem in the world. Due to this, a large number of deaths occur. But now this will not happen, because Japan has made such artificial blood, which is going to prove to be a game changer. It can be said that Japan has started a new era in the field of medicine which is going to be a game changer. It is purple in color.

This artificial blood is known as hemoglobin vasicals (HBVs). There are many characteristics of this blood. This is such artificial blood that is capable of transporting oxygen to every part of the body like real blood. It is based on hemoglobin, which is the part of red blood cells that bind and carry oxygen.

This technique of Japan uses hemoglobin particles of nano-shaped wrapped in lipid membrane, causing it to act as a small artificial red blood cells of 250 nanometers. Its purple color separates it from normal blood, which is red in color.

This blood will be universal blood. It can be given to a person with any blood group (A, B, AB, O), because it does not contain blood group markers. This will eliminate the need to mix blood group. This virus will be free, so it will not be at risk of virus like HIV, hepatitis.

How long can this blood be stored

The life of this blood is long. It can be stored for 2 years at room temperature, while normal blood rests for only 42 days. It can be made from old or expired donated blood, which will reduce blood wastage. It effectively delivers oxygen to the body like natural blood.

It has been created by Professor Hiromi Sakai and his team at Japan’s Nara Medical University. Adopted a unique process to make this. Hemoglobin is extracted from the old or expired donated blood. The hemoglobin is then wrapped in a nano-shaped lipid membrane, which provides stability and functionality.

It contains 250 nanometer size artificial cells, which act like natural red blood cells. High level purification techniques are used in the production process, making it completely safe.

Why this artificial blood game-changer

1. Complete blood deficiency
Blood deficiency is a serious problem worldwide. According to WHO, about 11.2 million units of blood are donated every year, but this is not enough to meet the demand. Especially under emergency situations such as surgery, accident or lack of blood during delivery, many people die. This artificial blood can meet this deficiency, as it can be made on a large scale. It can be used for any blood group.

2. Life protector in emergency

This artificial blood can be easily carried to far-flung areas by store at room temperature. This is an ideal solution for army, disaster relief teams and mobile hospitals.

3. Blood group matching no need
In the current era, if someone has to give blood, then the blood of the donor is first checked, the blood group is seen. They see how much is matching the person whom his blood is being given. Blood group matching is a complex process. Giving wrong blood groups can lead to serious condition, health can deteriorate badly.
This is not a problem in artificial blood, because it is universal. This allows physicians to make quick decisions and start treatment.

4. Use in surgery and medicine
Blood is required in cases of surgery, especially heart surgery, organ transplant or massive bleeding. Artificial blood can be available immediately under these conditions, which will help in saving the lives of patients.

5. Virus and freedom from infection

Traditional blood is at risk of virus or bacteria, but the production process of artificial blood makes it completely safe. This is particularly useful in areas where it is difficult to ensure purity of blood.

Testing on mice to humans

This artificial blood was tested at several levels in Japan. In the early experiments conducted on mice, 90% of the blood was replaced with this artificial blood. Their blood pressure, oxygen levels and other important signs were normal.
Its human trials started in 2020 with 10ml, 50ml, and 100ml dose in Japan. By 2025 and tested with 100–400ml dose, no serious side effects were observed.

Its production will be started on a large scale by 2030. It will be prepared for use all over the world.

What is difficult in this

Its cost is still very expensive. It is necessary to reduce costs for mass production, so that it can be accessible even in developing countries. Get approval from health regulatory organizations of different countries will be a complex process. More research is also needed to understand the effects of prolonged use.